These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19567611)

  • 21. [Severe alpha 1-antitrypsin deficiency: clinical observations of 21 patients].
    Dürst A; Grob PJ
    Schweiz Med Wochenschr; 1978 Dec; 108(51):2040-6. PubMed ID: 310577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha1-Antitrypsin deficiency is a possible first event in the two-event model of transfusion-related acute lung injury: a proposal and case report.
    Stack G; Tormey CA
    Transfusion; 2008 Nov; 48(11):2477-8. PubMed ID: 19054378
    [No Abstract]   [Full Text] [Related]  

  • 23. Principles and clinical management of alpha 1-antitrypsin deficiency.
    Scharnweber KS
    J Intraven Nurs; 1990; 13(4):226-9. PubMed ID: 2366117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose intravenous AAT and plasma neutrophil derived fibrinogen fragments.
    Stolk J; Nieuwenhuizen W; Stoller JK; Aboussouan L
    Thorax; 2005 Jan; 60(1):84; author reply 84. PubMed ID: 15618590
    [No Abstract]   [Full Text] [Related]  

  • 25. A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases.
    Morse JO; Lebowitz MD; Knudson RJ; Burrows B
    N Engl J Med; 1975 Feb; 292(6):278-81. PubMed ID: 1078596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the evidence that augmentation therapy helps asthma: are storks really responsible for new babies?
    Stoller JK
    Monaldi Arch Chest Dis; 2008 Dec; 69(4):155-6. PubMed ID: 19350836
    [No Abstract]   [Full Text] [Related]  

  • 27. Alpha-1-antitrypsin deficiency panniculitis presenting with severe anasarca, pulmonary embolus and hypogammaglobulinaemia.
    Elsensohn AN; Curtis JA; Secrest AM; Liaqat M; Florell SR; Duffy KL; Edholm K; Summers EM
    Br J Dermatol; 2015 Jul; 173(1):289-91. PubMed ID: 25495349
    [No Abstract]   [Full Text] [Related]  

  • 28. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual Acute Sequelae of α1-Antitrypsin Deficiency: A Myriad of Symptoms With One Common Cure.
    Franciosiz AN; McCarthy C; Carroll TP; McElvaney NG
    Chest; 2015 Nov; 148(5):e136-e138. PubMed ID: 26527439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activity of blood antitrypsin in patients with congenital lung diseases].
    Levashov IuN; Syromiatnikova NV; Iakovenko VIa; Kutovaia AP
    Klin Med (Mosk); 1975 Dec; 53(12):95-8. PubMed ID: 1083453
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment: comparisons of Aralast and Prolastin, alpha1-protease inhibitors for treatment of alpha1-antitrypsin deficiency.
    Petteway SR
    Ann Pharmacother; 2006 Feb; 40(2):353-4; author reply 354. PubMed ID: 16449545
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary abnormality and alpha 1-antitrypsin heterozygote deficiency in a working population (author's transl)].
    Girard F; Aug F; Camara M; Bohadana AB; Bagrel A; Museur G; Abraham S
    Bull Eur Physiopathol Respir; 1978; 14(1):11-22. PubMed ID: 313224
    [No Abstract]   [Full Text] [Related]  

  • 33. [From gene disease; alpha1-antitrypsine deficiency].
    Hiemstra PS; Stolk J
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):758-60. PubMed ID: 12731467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of oral 4-phenylbutyrate on serum alpha-1-antitrypsin in patients with alpha-1-antitrypsin deficiency: a preliminary study.
    Teckman JH
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):34-7. PubMed ID: 15187777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hereditary alpha-1-antitrypsin deficiency can cause COPD. Substitution treatment seems to result in fewer infections and prolonged survival].
    Janciauskiene S
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3631-4, 3637-8. PubMed ID: 18193673
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency.
    Köhnlein T; Janciauskiene S; Welte T
    Ther Adv Respir Dis; 2010 Oct; 4(5):279-87. PubMed ID: 20660539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of alpha 1-antitrypsin deficiency in normal healthy Indians and in patients with various pulmonary diseases.
    Shah AC; Dixit SD; Billimoria FP; Merchant HC; Unawala J
    J Indian Med Assoc; 1983 Sep; 81(5-6):79-82. PubMed ID: 6609210
    [No Abstract]   [Full Text] [Related]  

  • 38. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
    Blanco I; Canto H; de Serres FJ; Fernandez-Bustillo E; Rodríguez MC
    J Rheumatol; 2004 Oct; 31(10):2082-5. PubMed ID: 15468381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic and clinical aspects of the alpha1-antitrypsin.
    Talamo RC
    Pediatrics; 1975 Jul; 56(1):91-9. PubMed ID: 1099521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
    Bergin DA; Hurley K; McElvaney NG; Reeves EP
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.